Close Menu


Title: Methods and Compositions for Increasing RNA Interference
Patent Number: 8,865,668
Filed: Feb. 20, 2009

NEW YORK (GenomeWeb) — Rosetta Genomics said today that it is collaborating with the Institute of Molecular Translational Medicine (IMTM) at Palacky University in the Czech Republic to validate and develop a new thyroid cancer diagnostic tool.

NEW YORK (GenomeWeb) — Biocept and Rosetta Genomics said this week that they will pair Biocept's circulating tumor cell isolation technology with Rosetta's microRNA analysis platforms to investigate the possibility of developing blood-based cancer diagnostics and therapeutic response assays.

Title: RNA Interference-mediating Small RNA Molecules
Patent Number: 8,853,384
Filed: Dec. 2, 2009

NEW YORK (GenomeWeb) — Biocept and Rosetta Genomics said today that they will collaborate in the area of cancer diagnostics.

NEW YORK (GenomeWeb) – A new report from a team led by Fred Hutchinson Cancer Research Center (FHCRC) scientists indicates that exosomes, on average, harbor significantly fewer copies of microRNAs than previously believed, adding a new wrinkle to ongoing research into the role of these cell-deriv

Title: microRNA Affinity Assay and Uses Thereof
Patent Number: 8,846,350
Filed: Oct. 18, 2010

NEW YORK (GenomeWeb) – As part of an effort to advance conjugate-based drug-delivery technologies for siRNA therapeutics, researchers from China's Southern Medical University this month reported in vivo data on a new approach for tumor-targeted gene silencing.

This article has been updated to correct details regarding the amount Microlin owes under an intellectual property-licensing deal, as well as the number of its employees.

NEW YORK (GenomeWeb) – Regulus Therapeutics announced last week that it has initiated a natural history of disease study, called ATHENA, in patients with Alport syndrome.


A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.